Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Spdr S&p Biotech EtfETF ST STR SP BIOT | 431,215 | 445,005 | +13,790 | $40.92M | $41.26M | 9.86% | +$338.4K |
| Stereotaxis, Inc.(STXS) | 13,680,554 | 13,680,554 | 0 | $35.71M | $24.90M | 5.95% | -$10.81M |
| Merus N V | 378,995 | 409,445 | +30,450 | $17.07M | $24.23M | 5.79% | +$7.16M |
| Cytokinetics, Incorporated(CYTK) | 398,100 | 398,100 | 0 | $27.91M | $21.57M | 5.15% | -$6.34M |
| Revolution Medicines, Inc.(RVMD) | 511,894 | 511,894 | 0 | $16.50M | $19.87M | 4.75% | +$3.37M |
| IDEAYA Biosciences, Inc.(IDYA) | 446,341 | 422,213 | -24,128 | $19.59M | $14.82M | 3.54% | -$4.76M |
| AtriCure, Inc.(ATRC) | 271,029 | 639,173 | +368,144 | $8.24M | $14.55M | 3.48% | +$6.31M |
| Ishares Nasdaq Biotech IndxETF | 102,500 | 102,500 | 0 | $14.07M | $14.07M | 3.36% | +$4.1K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 659,574 | 657,074 | -2,500 | $15.70M | $13.49M | 3.22% | -$2.21M |
| Blueprint Medicines Corp | 106,763 | 104,763 | -2,000 | $10.13M | $11.29M | 2.70% | +$1.16M |
| Ascendis Pharma A/SADR(ASND) | 92,472 | 80,972 | -11,500 | $13.98M | $11.04M | 2.64% | -$2.94M |
| Xenon Pharmaceuticals Inc.(XENE) | 273,739 | 273,739 | 0 | $11.78M | $10.67M | 2.55% | -$1.11M |
| Viking Therapeutics, Inc.(VKTX) | 194,117 | 189,117 | -5,000 | $15.92M | $10.03M | 2.40% | -$5.89M |
| Neurocrine Biosciences, Inc.(NBIX) | 71,615 | 71,615 | 0 | $9.88M | $9.86M | 2.36% | -$17.9K |
| Kalvista Pharmaceuticals Inc | 806,973 | 806,973 | 0 | $9.57M | $9.51M | 2.27% | -$64.6K |
| Day One Biopharmaceuticals I COM | 666,463 | 666,463 | 0 | $11.01M | $9.18M | 2.19% | -$1.83M |
| Kura Oncology, Inc.(KURA) | 412,663 | 423,500 | +10,837 | $8.80M | $8.72M | 2.08% | -$82.2K |
| Tandem Diabetes Care, Inc.(TNDM) | 258,208 | 204,208 | -54,000 | $9.14M | $8.23M | 1.97% | -$915.6K |
| Morphic Holding Inc | 231,748 | 231,748 | 0 | $8.16M | $7.90M | 1.89% | -$261.9K |
| UroGen Pharma Ltd.(URGN) | 0 | 469,000 | +469,000 | $0 | $7.87M | 1.88% | +$7.87M |
| Biohaven Ltd.(BHVN) | 118,730 | 218,730 | +100,000 | $6.49M | $7.59M | 1.81% | +$1.10M |
| DexCom, Inc.(DXCM) | 65,552 | 65,552 | 0 | $9.09M | $7.43M | 1.78% | -$1.66M |
| Axogen, Inc.(AXGN) | 935,894 | 935,894 | 0 | $7.55M | $6.78M | 1.62% | -$776.8K |
| Edgewise Therapeutics, Inc.(EWTX) | 306,197 | 290,197 | -16,000 | $5.59M | $5.23M | 1.25% | -$358.6K |
| Larimar Therapeutics, Inc.(LRMR) | 656,373 | 639,974 | -16,399 | $4.98M | $4.64M | 1.11% | -$342.1K |
| Ascendis Pharma A/SNOTE 2 250 4 0(ASND) | 0 | 0 | 0 | $4.61M | $4.42M | 1.06% | -$190.0K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 709,500 | 704,500 | -5,000 | $3.60M | $4.35M | 1.04% | +$749.5K |
| Century Therapeutics, Inc.(IPSC) | 1,307,407 | 1,704,232 | +396,825 | $5.46M | $4.35M | 1.04% | -$1.12M |
| Alector Inc | 912,928 | 912,928 | 0 | $5.50M | $4.14M | 0.99% | -$1.35M |
| 2seventy Bio Inc | 1,204,051 | 1,050,709 | -153,342 | $6.44M | $4.05M | 0.97% | -$2.40M |
| Arcus Biosciences, Inc.(RCUS) | 231,717 | 253,217 | +21,500 | $4.37M | $3.86M | 0.92% | -$518.3K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,175 | 130,175 | 0 | $4.19M | $3.23M | 0.77% | -$965.9K |
| Insulet Corporation(PODD) | 15,900 | 15,900 | 0 | $2.73M | $3.21M | 0.77% | +$483.4K |
| Keros Therapeutics, Inc.(KROS) | 67,754 | 67,754 | 0 | $4.49M | $3.10M | 0.74% | -$1.39M |
| Acelyrin Inc | 202,587 | 693,609 | +491,022 | $1.37M | $3.06M | 0.73% | +$1.69M |
| Alkermes plcSHS(ALKS) | 0 | 120,700 | +120,700 | $0 | $2.91M | 0.69% | +$2.91M |
| Stoke Therapeutics, Inc.(STOK) | 145,000 | 207,427 | +62,427 | $1.96M | $2.80M | 0.67% | +$844.8K |
| Astria Therapeutics Inc | 223,265 | 274,165 | +50,900 | $3.14M | $2.49M | 0.60% | -$647.6K |
| Bicycle Therapeutics PlcADS | 122,200 | 122,200 | 0 | $3.04M | $2.47M | 0.59% | -$569.5K |
| Perspective Therapeutics, Inc.(CATX) | 0 | 231,634 | +231,634 | $0 | $2.31M | 0.55% | +$2.31M |
| Accuray Inc | 1,222,358 | 1,222,358 | 0 | $3.02M | $2.22M | 0.53% | -$794.5K |
| Iteos Therapeutics Inc | 98,560 | 144,360 | +45,800 | $1.34M | $2.14M | 0.51% | +$797.9K |
| ARS Pharmaceuticals, Inc.(SPRY) | 239,194 | 239,194 | 0 | $2.44M | $2.04M | 0.49% | -$409.0K |
| MediWound Ltd.SHS NEW(MDWD) | 188,753 | 124,479 | -64,274 | $2.69M | $1.93M | 0.46% | -$757.8K |
| BrainsWay Ltd.ADS(BWAY) | 297,655 | 297,655 | 0 | $1.57M | $1.81M | 0.43% | +$232.2K |
| Inogen, Inc.(INGN) | 208,790 | 208,790 | 0 | $1.68M | $1.70M | 0.41% | +$12.5K |
| Immatics N.V.SHS(IMTX) | 145,000 | 145,000 | 0 | $1.52M | $1.68M | 0.40% | +$160.9K |
| Regulus Therapeutics Inc | 1,070,548 | 895,200 | -175,348 | $3.08M | $1.60M | 0.38% | -$1.49M |
| Proqr Therapeutics N VSHS EURO SHS EURO | 905,582 | 905,582 | 0 | $2.07M | $1.50M | 0.36% | -$570.4K |
| COMPASS Pathways plcADS(CMPS) | 243,210 | 243,210 | 0 | $2.02M | $1.47M | 0.35% | -$554.5K |
| Allogene Therapeutics Inc | 0 | 605,100 | +605,100 | $0 | $1.41M | 0.34% | +$1.41M |
| Mineralys Therapeutics, Inc.(MLYS) | 90,000 | 119,000 | +29,000 | $1.16M | $1.39M | 0.33% | +$230.4K |
| Aquestive Therapeutics Inc | 500,000 | 530,000 | +30,000 | $2.13M | $1.38M | 0.33% | -$752.0K |
| Lineage Cell Therapeutics, Inc.(LCTX) | 1,366,308 | 1,350,708 | -15,600 | $2.02M | $1.35M | 0.32% | -$675.1K |
| Alto Neuroscience, Inc.(ANRO) | 10,000 | 120,000 | +110,000 | $153.5K | $1.28M | 0.31% | +$1.13M |
| Gossamer Bio, Inc.(GOSS) | 1,409,262 | 1,409,262 | 0 | $1.66M | $1.27M | 0.30% | -$393.3K |
| Immunovant, Inc.(IMVT) | 29,416 | 47,916 | +18,500 | $950.4K | $1.26M | 0.30% | +$314.6K |
| Sage Therapeutics Inc | 0 | 116,200 | +116,200 | $0 | $1.26M | 0.30% | +$1.26M |
| Autolus Therapeutics plcADS(AUTL) | 216,667 | 346,667 | +130,000 | $1.38M | $1.21M | 0.29% | -$175.9K |
| Centessa Pharmaceuticals PlcADS | 0 | 122,882 | +122,882 | $0 | $1.11M | 0.27% | +$1.11M |
| Tourmaline Bio Inc | 0 | 75,982 | +75,982 | $0 | $977.1K | 0.23% | +$977.1K |
| Sutro Biopharma, Inc.(STRO) | 334,079 | 329,579 | -4,500 | $1.89M | $965.7K | 0.23% | -$921.9K |
| PROCEPT BioRobotics Corporation(PRCT) | 54,995 | 13,994 | -41,001 | $2.72M | $854.9K | 0.20% | -$1.86M |
| PolyPid Ltd.(PYPD) | 185,446 | 184,846 | -600 | $853.1K | $794.8K | 0.19% | -$58.2K |
| Compugen Ltd.(CGEN) | 430,202 | 462,202 | +32,000 | $1.11M | $776.5K | 0.19% | -$333.4K |
| Nyxoah S ASHS SHS | 0 | 108,108 | +108,108 | $0 | $753.5K | 0.18% | +$753.5K |
| Adicet Bio Inc | 600,000 | 600,000 | 0 | $1.41M | $726.0K | 0.17% | -$684.0K |
| Acrivon Therapeutics Inc | 131,351 | 121,351 | -10,000 | $939.2K | $703.8K | 0.17% | -$235.3K |
| Syros Pharmaceuticals Inc | 135,850 | 135,850 | 0 | $726.8K | $701.0K | 0.17% | -$25.8K |
| ADC Therapeutics SASHS(ADCT) | 0 | 204,081 | +204,081 | $0 | $644.9K | 0.15% | +$644.9K |
| Terns Pharmaceuticals Inc | 0 | 86,000 | +86,000 | $0 | $585.7K | 0.14% | +$585.7K |
| Neuronetics, Inc.(STIM) | 313,717 | 313,717 | 0 | $1.49M | $564.7K | 0.13% | -$928.6K |
| Aprea Therapeutics, Inc.(APRE) | 137,174 | 137,174 | 0 | $917.7K | $558.3K | 0.13% | -$359.4K |
| Neurogene Inc.(NGNE) | 0 | 11,000 | +11,000 | $0 | $400.3K | 0.10% | +$400.3K |
| Masimo Corp | 3,000 | 3,000 | 0 | $440.6K | $377.8K | 0.09% | -$62.7K |
| Adaptimmune Therapeutics plcADR(ADAPY) | 341,064 | 341,064 | 0 | $538.9K | $332.5K | 0.08% | -$206.4K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 36,000 | +36,000 | $0 | $254.5K | 0.06% | +$254.5K |
| Foghorn Therapeutics Inc.(FHTX) | 0 | 41,850 | +41,850 | $0 | $240.6K | 0.06% | +$240.6K |
| Nevro Corp | 28,000 | 28,000 | 0 | $404.3K | $235.8K | 0.06% | -$168.6K |
| Structure Therapeutics IncADS | 0 | 5,000 | +5,000 | $0 | $196.3K | 0.05% | +$196.3K |
| Karyopharm Therapeutics Inc.(KPTI) | 192,678 | 192,678 | 0 | $290.9K | $167.2K | 0.04% | -$123.8K |
| Spero Therapeutics, Inc.(SPRO) | 125,000 | 125,000 | 0 | $215.0K | $162.5K | 0.04% | -$52.5K |
| Compass Therapeutics, Inc.(CMPX) | 116,882 | 116,882 | 0 | $231.4K | $116.9K | 0.03% | -$114.5K |
| BioNTech SEADS(BNTX) | 17,000 | 0 | -17,000 | $1.57M | $0 | — | -$1.57M |
| Perspective Therapeutics, Inc.(CATX) | 3,103,644 | 0 | -3,103,644 | $3.69M | $0 | — | -$3.69M |
| Vigil Neuroscience Inc | 71,815 | 0 | -71,815 | $244.9K | $0 | — | -$244.9K |